Related Experiment Videos
Promotora diabetes intervention for Mexican Americans
Josefina Lujan1, Sharon K Ostwald2, Melchor Ortiz3
1The University of Texas at El Paso (Ms Lujan)
The Diabetes Educator
|August 9, 2007
Summary
Community health workers called promotoras improved glycemic control and diabetes knowledge in Mexican Americans with type 2 diabetes. This intervention shows promise for managing diabetes in underserved populations.
Area of Science:
- Public Health
- Diabetes Management
- Health Disparities
Background:
- Type 2 diabetes disproportionately affects Mexican Americans.
- Effective interventions are needed to improve glycemic control and diabetes knowledge in this population.
- Culturally tailored approaches are crucial for engaging minority communities.
Purpose of the Study:
- To evaluate the effectiveness of a promotora-led intervention on glycemic control (A1C levels).
- To assess the intervention's impact on diabetes knowledge and health beliefs.
- To examine outcomes in Mexican Americans with type 2 diabetes along the Texas-Mexico border.
Main Methods:
- Randomized controlled trial with 150 Mexican American participants.
- Culturally specific intervention: group education, telephone contact, faith-based postcards.
- Measurements included A1C, diabetes knowledge, and health beliefs at 3 and 6 months.
Main Results:
- Significant improvement in A1C levels (P < .001) and diabetes knowledge (P < .002) at 6 months in the intervention group.
- No significant changes observed at the 3-month assessment.
- Health belief scores decreased in both intervention and control groups.
Conclusions:
- Promotora-led interventions can effectively decrease A1C levels and enhance diabetes knowledge.
- Integrating promotoras into interdisciplinary teams can yield positive outcomes for Mexican American patients with type 2 diabetes.
- Findings support culturally sensitive community health worker models for diabetes management.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...